Literature DB >> 12691833

Gene transfer of constitutively active protein kinase C into striatal neurons accelerates onset of levodopa-induced motor response alterations in parkinsonian rats.

Justin D Oh1, Alfred I Geller, Guo rong Zhang, Thomas N Chase.   

Abstract

Alterations in motor response that complicate levodopa treatment of Parkinson's disease appear to involve sensitization of striatal ionotropic glutamate receptors. Since protein kinase C (PKC)-mediated phosphorylation regulates glutamatergic receptors of the alpha-amino-3-hydroxyl-5-methyl-4-isoxazole propionic acid (AMPA) subtype and has been linked to several forms of behavioral plasticity, activation of PKC signaling in striatal spiny neurons may also contribute to the motor plasticity changes associated with chronic levodopa therapy. To evaluate this possibility, we sought to augment PKC signaling by using Herpes Simplex Virus type 1 vectors (pHSVpkcDelta) to directly transfer the catalytic domain of the PKCbetaII gene into striatal neurons of parkinsonian rats. Microinjection of pHSVpkcDelta vectors lead to the persistent expression of PkcDelta (35% loss over 21 days) in medium spiny neurons together with an increase in serine 831 phosphorylation on AMPA receptor GluR1 subunits and hastened the appearance of the shortened response duration produced by chronic levodopa treatment (P<0.05). In pHSVpkcDelta-infected animals, intrastriatal injection of the PKC inhibitor NPC-15437 (1.0 microg) attenuated both the increased GluR1 phosphorylation (P<0.01) and the accelerated onset of the levodopa-induced response modifications (P<0.01). However, in rats that received levodopa treatment for 21 days without the gene transfer, intrastriatal NPC-15437 had no effect on the response shortening or on GluR1 S831 phosphorylation. The results suggest that an increase in PKC-mediated signaling, including, in part, phosphorylation of AMPA receptors, on striatal spiny neurons may be sufficient to promote the initial appearance, but not necessary the ultimate expression, of the levodopa-induced motor response changes occurring in a rodent model of the human motor complication syndrome.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12691833      PMCID: PMC2581872          DOI: 10.1016/s0006-8993(03)02348-5

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  80 in total

1.  Long-term potentiation persistence greater in C57BL/6 than DBA/2 mice: predicted on basis of protein kinase C levels and learning performance.

Authors:  S Matsuyama; U Namgung; A Routtenberg
Journal:  Brain Res       Date:  1997-07-18       Impact factor: 3.252

2.  Calcium- and calmodulin-dependent phosphorylation of AMPA type glutamate receptor subunits by endogenous protein kinases in the post-synaptic density.

Authors:  Y Hayashi; A Ishida; H Katagiri; M Mishina; H Fujisawa; T Manabe; T Takahashi
Journal:  Brain Res Mol Brain Res       Date:  1997-06

3.  Subtype-specific regulation of recombinant NMDA receptor-channels by protein tyrosine kinases of the src family.

Authors:  G Köhr; P H Seeburg
Journal:  J Physiol       Date:  1996-04-15       Impact factor: 5.182

Review 4.  Modulation of levodopa-induced motor response complications by NMDA antagonists in Parkinson's disease.

Authors:  P J Blanchet; S M Papa; L V Metman; M M Mouradian; T N Chase
Journal:  Neurosci Biobehav Rev       Date:  1997-07       Impact factor: 8.989

5.  Protein kinase A inhibitor attenuates levodopa-induced motor response alterations in the hemi-parkinsonian rat.

Authors:  J D Oh; P Del Dotto; T N Chase
Journal:  Neurosci Lett       Date:  1997-05-30       Impact factor: 3.046

Review 6.  Protein kinase C in synaptic plasticity: changes in the in situ phosphorylation state of identified pre- and postsynaptic substrates.

Authors:  G M Ramakers; P Pasinelli; J J Hens; W H Gispen; P N De Graan
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1997-04       Impact factor: 5.067

Review 7.  Helper virus-free herpes simplex virus-1 plasmid vectors for gene therapy of Parkinson's disease and other neurological disorders.

Authors:  A I Geller; L Yu; Y Wang; C Fraefel
Journal:  Exp Neurol       Date:  1997-03       Impact factor: 5.330

Review 8.  Problems with current pharmacologic treatment of Parkinson's disease.

Authors:  H I Hurtig
Journal:  Exp Neurol       Date:  1997-03       Impact factor: 5.330

9.  MK-801 prevents levodopa-induced motor response alterations in parkinsonian rats.

Authors:  C Marin; S Papa; T M Engber; M Bonastre; E Tolosa; T N Chase
Journal:  Brain Res       Date:  1996-10-14       Impact factor: 3.252

10.  Helper virus-free transfer of herpes simplex virus type 1 plasmid vectors into neural cells.

Authors:  C Fraefel; S Song; F Lim; P Lang; L Yu; Y Wang; P Wild; A I Geller
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

View more
  6 in total

1.  Genetic enhancement of visual learning by activation of protein kinase C pathways in small groups of rat cortical neurons.

Authors:  Guo-Rong Zhang; Xiaodan Wang; Lingxin Kong; Xiu-Gui Lu; Brian Lee; Meng Liu; Mei Sun; Corinna Franklin; Robert G Cook; Alfred I Geller
Journal:  J Neurosci       Date:  2005-09-14       Impact factor: 6.167

2.  Ca2+/calmodulin-dependent protein kinase II inhibitors disrupt AKAP79-dependent PKC signaling to GluA1 AMPA receptors.

Authors:  Ian M Brooks; Steven J Tavalin
Journal:  J Biol Chem       Date:  2010-12-14       Impact factor: 5.157

3.  Characteristic and intermingled neocortical circuits encode different visual object discriminations.

Authors:  Guo-Rong Zhang; Hua Zhao; Nathan Cook; Michael Svestka; Eui M Choi; Mary Jan; Robert G Cook; Alfred I Geller
Journal:  Behav Brain Res       Date:  2017-05-13       Impact factor: 3.332

4.  Improved spatial learning in aged rats by genetic activation of protein kinase C in small groups of hippocampal neurons.

Authors:  Guo-Rong Zhang; Meng Liu; Haiyan Cao; Lingxin Kong; Xiaodan Wang; Jennifer A O'Brien; Shuo-Chieh Wu; Robert G Cook; Alfred I Geller
Journal:  Hippocampus       Date:  2009-05       Impact factor: 3.899

Review 5.  The molecular pharmacology and cell biology of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors.

Authors:  Claire L Palmer; Lucy Cotton; Jeremy M Henley
Journal:  Pharmacol Rev       Date:  2005-06       Impact factor: 25.468

Review 6.  Convergent evidence for abnormal striatal synaptic plasticity in dystonia.

Authors:  David A Peterson; Terrence J Sejnowski; Howard Poizner
Journal:  Neurobiol Dis       Date:  2009-12-18       Impact factor: 5.996

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.